Dosage Information for Mavenclad: Formulation, Potency, Administration Methods, and Additional Details
Mavenclad, a brand-name medication approved by the FDA, is used to treat certain types of multiple sclerosis (MS) in adults, including relapsing-remitting MS and active secondary progressive MS. This medication is meant to be used as a long-term treatment.
The typical dosing for MS involves two treatment courses over a total of 2 years. Each treatment course includes two cycles per year, about a month apart. Each cycle is 4 or 5 days long. During treatment cycles, one or two tablets of Mavenclad are taken per day, depending on the patient's weight. The dosage is determined by body weight in kilograms, with a usual dosing of 3.5 mg of the drug per kg of body weight.
Mavenclad is available in one strength: 10 milligrams (mg). It comes as oral tablets and does not have a generic version. The active ingredient in Mavenclad is cladribine, which belongs to a group of medications called antimetabolites.
It's crucial to follow the dosage prescribed by your doctor. If a dose of Mavenclad is missed, it should be skipped for now and the treatment cycle extended by the corresponding number of days to take the missed dose. After two treatment courses, one should not take the drug again for at least 2 years due to an increased risk of cancer.
Mavenclad should be taken 3 hours before or after any other medications that are taken by mouth. It's also important to keep Mavenclad tablets in their original package until ready to take, and to wash hands after taking the dose.
Mavenclad has a Boxed Warning from the Food and Drug Administration (FDA) regarding the risk of cancer, which is the most serious type of warning. Never take more Mavenclad than prescribed by your doctor, and call your doctor immediately if you believe you've taken too much.
For more information about Mavenclad, refer to additional articles on the subject. Mavenclad is not approved for use in children.
[1] Source: FDA-approved prescribing information for Mavenclad.
- This medication, Mavenclad, is used to treat certain types of multiple sclerosis in adults, including relapsing-remitting MS and active secondary progressive MS, acting as a long-term treatment.
- The typical dosing for multiple sclerosis involves two treatment courses over a total of 2 years, each treatment course including two cycles per year, approximately a month apart.
- Each cycle lasts 4 or 5 days, with patients taking one or two tablets of Mavenclad per day, depending on their weight, and the dosage being determined by body weight in kilograms.
- Mavenclad, with the active ingredient cladribine, a member of the antimetabolites group, is only available in 10 milligrams and comes as oral tablets, without a generic version.
- It's essential to adhere to the dosage prescribed by the deciders in medical-health and follow the instructions provided, such as taking Mavenclad 3 hours before or after any other oral medications.
- Mavenclad has a Boxed Warning from the Food and Drug Administration regarding the risk of cancer - the most serious type of warning, emphasizing the importance of adhering to the given dosage and contacting your doctor if any concerns about overdose arise.
